Biomedicines (May 2024)

Unveiling Novel Structural Biomarkers for the Diagnosis of Glaucoma

  • Yu-Chien Tsai,
  • Hsin-Pei Lee,
  • Ta-Hsin Tsung,
  • Yi-Hao Chen,
  • Da-Wen Lu

DOI
https://doi.org/10.3390/biomedicines12061211
Journal volume & issue
Vol. 12, no. 6
p. 1211

Abstract

Read online

Glaucoma, a leading cause of irreversible blindness, poses a significant global health burden. Early detection is crucial for effective management and prevention of vision loss. This study presents a collection of novel structural biomarkers in glaucoma diagnosis. By employing advanced imaging techniques and data analysis algorithms, we now can recognize indicators of glaucomatous progression. Many research studies have revealed a correlation between the structural changes in the eye or brain, particularly in the optic nerve head and retinal nerve fiber layer, and the progression of glaucoma. These biomarkers demonstrate value in distinguishing glaucomatous eyes from healthy ones, even in the early stages of the disease. By facilitating timely detection and monitoring, they hold the potential to mitigate vision impairment and improve patient outcomes. This study marks an advancement in the field of glaucoma, offering a promising avenue for enhancing the diagnosis and possible management.

Keywords